15
Participants
Start Date
December 31, 2000
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2014
Plasma exchange
A course of plasma exchange of 5 treatments over 10 days, then administration of cyclophosphamide.
Cyclophosphamide
For GFR \> 50 ml/min/1.73 m2 received oral cyclophosphamide at a dose of 2 mg/kg/ day for 3 months. For GFR \< 50 ml/min/1.73 m2 but \> 10 ml/min/1.73 m2 will receive oral cyclophosphamide at a 25% reduced dose or 1.5 mg/kg/d for 3 months.
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH